Company news
Acrux Limited news in 2022
Acrux Limited's news releases, calls and decks from 2022, newest first.
Launch of prilocaine and lidocaine cream in United States
December 20, 2022
Mutual Termination of Co-Development Agreement
December 15, 2022
Chairman and CEO address to AGM
November 22, 2022
Remaining balance of R&D Tax Incentive Rebate received
October 2, 2022
Appendix 4E and FY22 Annual Report
August 25, 2022
Acruxs sixth generic dossier accepted by FDA for review
August 7, 2022
Acrux announces commercial agreement with Padagis
June 20, 2022
Successful patent litigation outcome
May 29, 2022
Appendix 4D, Half Year Accounts as at 31 December 2021
February 24, 2022